Contemporary Management of HIV: ART Management in Heavily Treatment Experienced Patients

Join 2 leading experts for an interactive Webinar on assessing virologic failure in patients with HIV and current options for patients with multidrug resistance, including case-based discussions on optimal approaches for managing patients with extensive treatment histories.

October 22, 2020 at 1:00 PM ET– For clinicians in DC, Maryland, and the Virginias

October 22, 2020 at 4:00 PM ET– For clinicians in Pennsylvania, Ohio, Indiana, and Kentucky

October 27, 2020 at 10:30 AM PT– For clinicians in Western US

October 27, 2020 at 3:00 PM ET– For clinicians in New York and New England Region

October 28, 2020 at 1:30 PM ET – For clinicians in the New Jersey and Delaware

October 28, 2020 at 6:00 PM CT – For clinicians in Southeast US

October 29, 2020 at 12:00 PM CT – For clinicians in the Midwest region

October 29, 2020 at 4:00 PM ET– For clinicians in Florida

November 4, 2020 at 12:00 PM ET – For clinicians in the Carolinas

November 4, 2020 at 6:00 PM CT– For clinicians in Southwest US


The timing and agenda for each webinar is as follows:

  • Introduction and program overview (5 mins)
  • Update and discussion on assessment of virologic failure and current ART options for patients with multiclass resistance (20-25 mins)
  • Case-based discussion on selecting next line therapy for patients with extensive treatment histories (45-50 mins)
  • Question and answer session (15 mins)


Date / Time
Event Details


Program Director
Joseph J. Eron, Jr., MD

Professor of Medicine and Epidemiology
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina

Program Director
Princy N. Kumar, MD, FIDSA, MACP

Professor of Medicine and Microbiology
Division of Infectious Diseases and Travel Medicine
Senior Associate Dean of Students
Georgetown University School of Medicine
Washington, DC

Jonathan Appelbaum, MD, FACP, AAHIVS

Laurie L. Dozier Jr, MD, Education Director
Professor of Internal Medicine
Department of Clinical Sciences
Florida State University College of Medicine
Tallahassee, Florida

Roger Bedimo, MD, MS, FACP

Professor of Medicine
Division of Infectious Diseases
University of Texas Southwestern Medical Center
Section Chief
Division of Infectious Diseases
Department of Internal Medicine
VA North Texas Health Care System
Dallas, Texas

Michelle S. Cespedes, MD, MS

Associate Professor of Medicine Division of Infectious Diseases
Icahn School of Medicine at Mount Sinai
New York City, NY

Eric S. Daar, MD

Chief, Division of HIV Medicine
Harbor-UCLA Medical Center
Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

Carlos del Rio, MD

Department of Medicine
Emory University School of Medicine
Atlanta, Georgia

Monica Gandhi, MD, MPH

Professor of Medicine
Division of HIV, Infectious Diseases, and Global Medicine
University of California, San Francisco
Medical Director
Ward 86 HIV Clinic
San Francisco General Hospital
San Francisco, California

Jason Halperin, MD, MPH

Assistant Professor of Medicine
Department of Infectious Diseases
Tulane University
Infectious Disease Physician
New Orleans, Louisiana

W. David Hardy, MD

Scientific and Medical Consultant
Adjunct Professor of Medicine

Division of Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, Maryland

Daniel R. Kuritzkes, MD

Chief, Division of Infectious Diseases
Brigham and Women's Hospital
Harriet Ryan Albee Professor of Medicine
Harvard Medical School
Boston, Massachusetts


Clinical Professor of Medicine
Department of Internal Medicine and Infectious Disease
University of Pennsylvania
Chief Scientific Officer
Philadelphia FIGHT
Philadelphia, Pennsylvania

Renslow D. Sherer, MD

Director, International HIV Training Center
Professor of Medicine
University of Chicago
Chicago, Illinois

Shobha Swaminathan, MD

Associate Professor
Division of Infectious Diseases
Department of Medicine
Rutgers New Jersey Medical School
Newark, New Jersey

Alan J. Taege, MD, FIDSA

Assistant Professor of Medicine
Department of Medicine
Cleveland Clinic Lerner College of Medicine
Staff Physician
Department of Infectious Disease
Cleveland Clinic
Cleveland, Ohio

Babafemi Taiwo, MBBS

Gene Stollerman Professor of Medicine
Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, Illinois

David A. Wohl, MD

Professor of Medicine
School of Medicine
Site Leader,  AIDS Clinical Trials Unit-Chapel Hill
University of North Carolina at Chapel Hill
Director, North Carolina AIDS Training and Education Center
Chapel Hill, North Carolina
Co-Director, HIV Services
North Carolina Department of Correction
Raleigh, North Carolina

This educational activity is not certified for CME/CE credit.

Goal Statement
The goal of this activity is to improve learners’ competence in providing optimal care for HIV-infected patients through the appropriate use of contemporary ARV regimens.

Target Audience
This program is intended for physicians, registered nurses, physician assistants, pharmacists, and other healthcare professionals who provide care for patients with HIV infection.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Perform appropriate assessments of patients with virologic failure in the setting of extensive treatment history and complex resistance, assessing factors contributing to failure and clinical and laboratory parameters relevant to the selection of a new regimen
  • Appropriately counsel patients on potential management strategies for virologic failure in the setting of an extensive treatment history and multiclass drug resistance
  • Describe the mechanisms of action, efficacy, and safety of agents with activity against multidrug-resistant HIV in treatment-experienced patients


Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation 

CCO designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours.

Pharmacist Continuing Education

CCO designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education. UAN: JA4008176-0000-20-109-L02-P

Activity type: Application

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.